BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25039309)

  • 1. Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice.
    Augustin M; Mrowietz U; Bonnekoh B; Rosenbach T; Thaçi D; Reusch M; Ardabili M; Reich K
    J Dtsch Dermatol Ges; 2014 Aug; 12(8):667-82. PubMed ID: 25039309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.
    Sawyer L; Samarasekera EJ; Wonderling D; Smith CH
    Br J Dermatol; 2013 May; 168(5):1095-105. PubMed ID: 23374249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
    Neri L; Miracapillo A
    G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
    Freeman K
    Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
    Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
    J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.
    van der Vleuten CJ; van de Kerkhof PC
    Drugs; 2001; 61(11):1593-8. PubMed ID: 11577796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
    J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation.
    Shepherd J; Taheri A; Feldman SR
    Clin Cosmet Investig Dermatol; 2013 Dec; 7():19-22. PubMed ID: 24379688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Chan CS; Van Voorhees AS; Lebwohl MG; Korman NJ; Young M; Bebo BF; Kalb RE; Hsu S
    J Am Acad Dermatol; 2009 Jun; 60(6):962-71. PubMed ID: 19375191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice.
    Oostveen AM; de Jong EM; Donders AR; van de Kerkhof PC; Seyger MM
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1193-7. PubMed ID: 25307472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In touch with psoriasis: topical treatments and current guidelines.
    Murphy G; Reich K
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():3-8. PubMed ID: 21507077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
    Stein Gold LF
    Semin Cutan Med Surg; 2016 Mar; 35(2 Suppl 2):S36-44; quiz S45. PubMed ID: 27074696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
    Maul JT; Anzengruber F; Conrad C; Cozzio A; Häusermann P; Jalili A; Kolios AGA; Laffitte E; Lapointe AK; Mainetti C; Schlapbach C; Trüeb R; Yawalkar N; Dippel M; Navarini AA
    Dermatology; 2021; 237(2):166-178. PubMed ID: 33406520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are topical keratolytic agents needed in the treatment of scalp psoriasis?
    Shokeen D; O'Neill JL; Taheri A; Feldman SR
    Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.